Literature DB >> 24690988

Expression of toll-like receptors 2, 4 and nuclear factor kappa B in mucosal lesions of human otitis: pattern and relationship in a clinical immunohistochemical study.

Snezana Jesic, Ana Jotic, Nada Tomanovic, Maja Zivkovic.   

Abstract

OBJECTIVES: The objectives were to detect and compare the expression of toll-like receptors (TLRs) 2, 4 and nuclear factor kappa B in mucosal lesions of chronic otitis.
METHODS: Fifty-five tissue samples obtained from children and adults operated on for otitis were investigated by semiquantitative immunohistochemical methods using polyclonal antibodies for TLR 2, 4 and NFkappaB. Kruskal-Wallis, Mann-Whitney, and Kendall's tau rank correlation tests were used.
RESULTS: Stronger expression of TLR2, 4 was found in inflamed mucosa than in the control for children and adults (TLR2: H = 23.86, P < .0011; TLR4: H = 22.80, P < .00 1) (TLR2: H = 17.53, P < .001; TLR4: H = 11.99, P < .001); in cholesteatoma perimatrix compared to tubotympanic lesions in children (TLR2: H = 11.06, P = .004; TLR4: H = 10.61, P = .005) and adults (TLR2: H = 10.73, P = .013; TLR4: H = 9.65, P = .021). No differences were found in NFkB expression (H = 0.042, P = .99). Significant correlations were found for all pairs of molecules in cholesteatoma and tubotympanic mucosa of adults (TLR2, 4: P = .002, P < .001; TLR2-NfkappaB: P = .032, P = .021; TLR4-NFkB: P = .035, P = .0013), only TLR4-NFkappaB in tubotympanic otitis of children (P = .026).
CONCLUSIONS: Toll-like receptors 2,4 and NFkB mediate inflammation in cholesteatoma and mucosal lesions oftubotympanic otitis in children and adults. Significant correlations betweenall pairs of molecules in all samples were detected in adults, but only TLR4-NFkappaB in children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24690988     DOI: 10.1177/0003489414527229

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  6 in total

1.  CUEDC2 Protects Against Experimental Colitis and Suppresses Excessive Proliferation of Intestinal Mucosa.

Authors:  Shaoxin Wang; Jiang Pu; Na Li; Chuanfeng Li; Chao Li; Lan Yu; Xiaohui Wang; Shanfeng Fu; Lihong Cui
Journal:  Dig Dis Sci       Date:  2015-07-17       Impact factor: 3.199

2.  Bone Marrow Mesenchymal Stem Cells Inhibit Lipopolysaccharide-Induced Inflammatory Reactions in Macrophages and Endothelial Cells.

Authors:  Dequan Li; Cong Wang; Chuang Chi; Yuanyuan Wang; Jing Zhao; Jun Fang; Jingye Pan
Journal:  Mediators Inflamm       Date:  2016-01-26       Impact factor: 4.711

Review 3.  Understanding the aetiology and resolution of chronic otitis media from animal and human studies.

Authors:  Mahmood F Bhutta; Ruth B Thornton; Lea-Ann S Kirkham; Joseph E Kerschner; Michael T Cheeseman
Journal:  Dis Model Mech       Date:  2017-11-01       Impact factor: 5.758

4.  Immunomodulation as a Protective Strategy in Chronic Otitis Media.

Authors:  Anke Leichtle; Arwa Kurabi; David Leffers; Markus Därr; Clara Sophia Draf; Allen Frederic Ryan; Karl-Ludwig Bruchhage
Journal:  Front Cell Infect Microbiol       Date:  2022-03-30       Impact factor: 5.293

Review 5.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

Review 6.  Current Understanding of Host Genetics of Otitis Media.

Authors:  Ruishuang Geng; Qingzhu Wang; Eileen Chen; Qing Yin Zheng
Journal:  Front Genet       Date:  2020-02-07       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.